Capuano, C., Pighi, C., Molfetta, R., Paolini, R., Battella, S., Palmieri, G., . . . Galandrini, R. (2017). Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production. Oncoimmunology.
Chicago ZitierstilCapuano, Cristina, et al. "Obinutuzumab-mediated High-affinity Ligation of FcγRIIIA/CD16 Primes NK Cells for IFNγ Production." Oncoimmunology 2017.
MLA ZitierstilCapuano, Cristina, et al. "Obinutuzumab-mediated High-affinity Ligation of FcγRIIIA/CD16 Primes NK Cells for IFNγ Production." Oncoimmunology 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.